Currently out of the existing stock ratings of Andrew Mok, 26 are a SELL (11.5%), 61 are a HOLD (26.99%), 139 are a BUY (61.5%).

Andrew Mok

Work Performance Price Targets & Ratings Chart

Analyst Andrew Mok, currently employed at BARCLAYS, carries an average stock price target met ratio of 52.39% that have a potential upside of 12.62% achieved within 83 days. Previously, Andrew Mok worked at UBS.

Andrew Mok’s has documented 471 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CI, Cigna Corp at 05-Jan-2026.

Wall Street Analyst Andrew Mok

Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for AGL (AGILON HEALTH) at 11/11/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.16 (7.41%) receiving and performance score of 74.07.

Average potential price target upside

of $65.28 (22.78%) on ELV (ELEVANCE HEALTH).
of $52.08 (13.9%) on UNH (UNITEDHEALTH GROUP).
of $51.88 (16.96%) on HCA (HCA HOLDINGS).

AMED Amedisys CYH Community Health Systems THC Tenet Healthcare UHS Universal Health Services EHC Encompass Health Corp HCA HCA Holdings ACHC Acadia Healthcare Company LHCG LHC Group OSH Oak Street Health DVA DaVita HealthCare Partners CANO Cano Health CMAX CareMax EHAB Enhabit PRVA Privia Health Group ALHC Alignment Healthcare LLC CI Cigna Corp CNC Centene Corp CVS CVS Health Corp ELV Elevance Health HUM Humana MOH Molina Healthcare RDNT RadNet ADUS Addus HomeCare AGL agilon health AVAH Aveanna Healthcare Holdings OSCR Oscar Health SGRY Surgery Partners UNH UnitedHealth Group

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score